Dr.  Ettensohn is the Co-Founder, President, and Managing Partner of Focal Point. He graduated from the University of Louisville School of Medicine and completed his psychiatry residency program at the University of Florida College of Medicine, where he served as Chief Resident for the University of Florida Department of Psychiatry.

He also completed an ECT fellowship at Emory University and an administrative fellowship at the American Board of Psychiatry and Neurology. As a diplomate of the American Board of Psychiatry and Neurology, he serves as an ambassador and committee member for The Board. He is also an active member of the American Psychiatric Association, The Florida Psychiatric Society, and the American Society of Ketamine Physicians.

He has been providing ketamine therapy since 2016 and established the private practice Cornerstone Psychiatric Care in 2020, which continues to utilize ketamine therapy. He and the other Focal Point cofounders found a huge disparity in patient access to the lifesaving treatments of ketamine therapy.

He along with his cofounders, continue to work with practices B2B to provide the tools for improving all medical patient-provider-payer platforming. His mission is to enable provider autonomy, as he has a personal understanding of how this improves patient care.